News from the FDA/CDC
News from the FDA/CDC
Measles cases continue to decline
Only two new cases were reported during the week ending Sept. 5.
News
FDA approves nintedanib for scleroderma interstitial lung disease
Interstitial lung disease affects half of scleroderma patients in the United States, and until now there was no treatment.
News from the FDA/CDC
New measles outbreak reported in western N.Y.
CDC: United States now more than 1,200 confirmed measles cases in 2019.
News
HHS proposes pathways for drug importation
Officials at the U.S. Department of Health and Human Services have announced a new plan that they say would lay the foundation for safe...
News from the FDA/CDC
FDA finds increased blood clot, death risk associated with Xeljanz
The agency announced newly approved warnings and a new limitation on the approved indication for ulcerative colitis.
News
Hadlima approved as fourth adalimumab biosimilar in U.S.
Hadlima gets seven of Humira’s indications.
News
FDA approves Otezla for treatment of Behçet’s-associated oral ulcers
The approval is based on the results of the randomized, placebo-controlled, double-blind, phase 3 RELIEF trial.
News from the FDA/CDC
New measles outbreaks reported in Los Angeles and El Paso
Measles cases now have occurred in 30 states this year.
News from the FDA/CDC
Measles cases have slowed but not stopped
CDC removes California from the list of active measles outbreaks.
News from the FDA/CDC
ACIP extends HPV vaccine coverage
Committee voted for catch-up vaccination for all individuals through age 26 years, optional for older adults.
News from the FDA/CDC
Measles incidence has slowed as summer begins
New York continues to be the measles hot spot, with more than half of the new cases last week occurring there.